Go offline with the Player FM app!
Angeli Möller | Building the Future of Health with Precision, Vision, and Heart (SPARK20 – 142)
Manage episode 488926428 series 2792478
How do you lead at the cutting edge of health, data, and AI—while staying deeply human?
Angeli Möller has led global data science teams across pharma giants, co-founded one of Europe’s most ambitious AI alliances, and now builds high-performance biotech strategies with precision. But what truly sets her apart isn’t just her technical fluency—it’s her clarity, courage, and care in how she builds teams, solves problems, and pushes the boundaries of innovation.
In this episode, Angeli opens up about the quiet frustrations that fuel her mission, the invisible cost of ignoring innovation, and the principles that guide her client work today. Whether you’re an investor, founder, or policymaker, her journey will reshape how you think about leadership, AI, and what truly moves the needle in healthcare.
Here’s what you’ll take away:
- Why most AI projects fail—and how to spot the ones that won’t.
- How to lead technical teams with vision, warmth, and accountability.
- Why proprietary data matters more than fancy algorithms.
- What real innovation feels like—and how to know when you’re missing it.
At the center of it all: a calm, fiercely smart leader who sees through the noise and builds what matters.
As she says:
“Start with the real problem. If you don’t understand the problem, AI won’t help you.”
Timestamps & Topics
📌 (01:08) Missed AI Integration Costs – “It’s faster, more effective, cheaper—but it’s not part of the core business yet.”
📌 (03:57) AI vs. Real-World Drug Impact – “The question isn’t: does it use AI? It’s: does the medicine work?”
📌 (04:48) Post-Hype AI Fallout in Pharma – “Fraud led to disillusionment. And investors paid the price.”
📌 (06:39) Corporate Blind Spots in Innovation – “It’s a danger in business to think there’s nothing to learn from others.”
📌 (09:40) Building a European AI Alliance – “At first, pharma didn’t take us seriously. That changed with the data.”
📌 (11:02) Data Ethics and Regulatory Risk – “You can massively hurt your business through accidental bias.”
📌 (13:19) Data Access for Rare Diseases – “The only solution is to make that data safely available.”
📌 (15:22) Leadership Shift: From Bayer to Startup – “It felt too obvious. I needed something riskier, more meaningful.”
📌 (21:23) Three Core Leadership Traits – “Vision. Technical understanding. And knowing when to bring in others.”
📌 (22:27) Frictionless Health Tech Adoption – “It’s inevitable. The economics—and behavior nudges—are already shaping it.”
This episode offers more than insight—it’s a playbook for building what’s next in health, tech, and leadership.
👉 Listen now, and share it with someone ready to shape the future.
Join the Podcast Newsletter: Link
201 episodes
Manage episode 488926428 series 2792478
How do you lead at the cutting edge of health, data, and AI—while staying deeply human?
Angeli Möller has led global data science teams across pharma giants, co-founded one of Europe’s most ambitious AI alliances, and now builds high-performance biotech strategies with precision. But what truly sets her apart isn’t just her technical fluency—it’s her clarity, courage, and care in how she builds teams, solves problems, and pushes the boundaries of innovation.
In this episode, Angeli opens up about the quiet frustrations that fuel her mission, the invisible cost of ignoring innovation, and the principles that guide her client work today. Whether you’re an investor, founder, or policymaker, her journey will reshape how you think about leadership, AI, and what truly moves the needle in healthcare.
Here’s what you’ll take away:
- Why most AI projects fail—and how to spot the ones that won’t.
- How to lead technical teams with vision, warmth, and accountability.
- Why proprietary data matters more than fancy algorithms.
- What real innovation feels like—and how to know when you’re missing it.
At the center of it all: a calm, fiercely smart leader who sees through the noise and builds what matters.
As she says:
“Start with the real problem. If you don’t understand the problem, AI won’t help you.”
Timestamps & Topics
📌 (01:08) Missed AI Integration Costs – “It’s faster, more effective, cheaper—but it’s not part of the core business yet.”
📌 (03:57) AI vs. Real-World Drug Impact – “The question isn’t: does it use AI? It’s: does the medicine work?”
📌 (04:48) Post-Hype AI Fallout in Pharma – “Fraud led to disillusionment. And investors paid the price.”
📌 (06:39) Corporate Blind Spots in Innovation – “It’s a danger in business to think there’s nothing to learn from others.”
📌 (09:40) Building a European AI Alliance – “At first, pharma didn’t take us seriously. That changed with the data.”
📌 (11:02) Data Ethics and Regulatory Risk – “You can massively hurt your business through accidental bias.”
📌 (13:19) Data Access for Rare Diseases – “The only solution is to make that data safely available.”
📌 (15:22) Leadership Shift: From Bayer to Startup – “It felt too obvious. I needed something riskier, more meaningful.”
📌 (21:23) Three Core Leadership Traits – “Vision. Technical understanding. And knowing when to bring in others.”
📌 (22:27) Frictionless Health Tech Adoption – “It’s inevitable. The economics—and behavior nudges—are already shaping it.”
This episode offers more than insight—it’s a playbook for building what’s next in health, tech, and leadership.
👉 Listen now, and share it with someone ready to shape the future.
Join the Podcast Newsletter: Link
201 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.